Prof. Backman will be using his expertise in nanoimaging and physico-chemical analysis of chromatin as well as the nano-imaging platform developed in his lab to develop and validate the ISOCT probe as well as EIBS related prediction rules for advanced stage adenomas in an attempt to elucidate the molecular mechanisms involved in metabolic reprogramming of cells. Prof. Backman will also be involved in the identification of secondary metabolic events as potential adenoma prevention strategy. Change of FTE from BMC to BCM; no changes in SOW.
|Effective start/end date||3/10/21 → 3/9/24|
- Baylor College of Medicine (7000001387//5R01CA224911-05)
- National Cancer Institute (7000001387//5R01CA224911-05)
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.